LNSR241115C2500
- 0.00
- 0.000.00%
LENSAR Newsroom
Q3 2024 LENSAR Inc Earnings Call
BTIG Maintains LENSAR(LNSR.US) With Buy Rating, Raises Target Price to $10
LENSAR | 10-Q: Quarterly report
LENSAR Q3 2024 GAAP EPS $(0.13) Beats $(0.27) Estimate, Sales $13.539M Beat $11.500M Estimate
Express News | Corrected-LENSAR Q3 Revenue USD 13.5 Million (Corrects Amount)
Express News | LENSAR Q3 Adjusted Ebitda USD 429 Thousand
Lensar 3Q Rev $13.5M >LNSR
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8
Earnings Preview: LENSAR to Report Financial Results Pre-market on November 07
$LENSAR(LNSR.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $LENSAR(LNSR.US)$ to post revenue of USD11.50M for 2024Q3, up 17.41%
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems
LENSAR to Participate in Two Upcoming Investor Conferences
LENSAR (LNSR) Gets a Buy From Lake Street
LENSAR Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
LENSAR | 10-Q: Q2 2024 Earnings Report
LENSAR Ends Ophthalmic Device Agreement With Oertli Instrumente
Express News | LENSAR- on Aug 5, Co, Oertli Instrumente AG Entered Termination Agreement Mutually Agreeing to Terminate Development Agreement, Effective Immediately
LENSAR Q2 2024 Adj. EPS $(0.46) Misses $(0.29) Estimate, Sales $12.636M Beat $12.150M Estimate
Express News | LENSAR Inc: Qtrly Shr Loss $0.79